Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▼Date fromSubject
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)64788ACCUZIDE 20 (tbl flm 30x20 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 6.4.2020Pfizer Europe MA EEIG (PFI-BE-3)64788ACCUZIDE 20 (tbl flm 30x20 mg/12,5 mg (blis. PVC/PVDC/Al))7.4.2020O
 21.2.2023Zentiva, k.s. (ZNT-1)15284Acidum folicum Léčiva (tbl obd 30x10 mg (blis. PVC/Al))21.2.2023R
 13.3.2023Zentiva, k.s. (ZNT-1)15284Acidum folicum Léčiva (tbl obd 30x10 mg (blis. PVC/Al))15.3.2023O
 20.3.2023Zentiva, k.s. (ZNT-1)2115DAcidum folicum Léčiva (tbl obd 45x10 mg (blis. PVC/Al))20.3.2023R
 30.4.2020Herbacos Recordati s.r.o. (HEO-1)88690ACIFEIN (tbl 10 (blis.PVC/Al))5.5.2020O
 24.3.2020Herbacos Recordati s.r.o. (HEO-1)88690ACIFEIN (tbl 10 (blis.PVC/Al))26.3.2020R
 21.5.2021Herbacos Recordati s.r.o. (HEO-1)88690ACIFEIN (tbl 10 (blis.PVC/Al))21.5.2021R
 2.6.2022Herbacos Recordati s.r.o. (HEO-1)5728DACIFEIN (tbl 20 (2x10) (blis.PVC/Al))2.6.2022Z
 2.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-4)90197Aclasta 5 mg infúzny roztok (sol inf 1x100 ml/5 mg (fľ.plast.))1.12.2022R
 7.2.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-4)90197Aclasta 5 mg infúzny roztok (sol inf 1x100 ml/5 mg (fľ.plast.))7.2.2023O
 4.10.2019KRKA, d.d., Novo mesto (KRK-2)7836AAclexa 100 mg tvrdé kapsuly (cps dur 30x100 mg (blis.PVC/Al))14.10.2019R
 29.10.2019KRKA, d.d., Novo mesto (KRK-2)7836AAclexa 100 mg tvrdé kapsuly (cps dur 30x100 mg (blis.PVC/Al))4.11.2019O
 29.10.2019KRKA, d.d., Novo mesto (KRK-2)7848AAclexa 200 mg tvrdé kapsuly (cps dur 90x200 mg (blis.PVC/Al))16.12.2019R
 16.2.2023KRKA, d.d., Novo mesto (KRK-2)7848AAclexa 200 mg tvrdé kapsuly (cps dur 90x200 mg (blis.PVC/Al))20.2.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)